# AVSOLA

NDC: 55513-670
Generic name: infliximab-axxq
Labeler / Manufacturer: Amgen, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20191212

FDA application: BLA761086

## Active ingredients

- INFLIXIMAB: 100 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-670"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-670
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de34bcb7-b524-45c8-9181-61c6f48d540e